Skip to content

Clinical trials

Observational Kidney Neoplasms trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Kidney Neoplasms Phase: Observational Country / region: China Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20071
20131
20191
20211
20223
20242
20254
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting10
Completed4
Unknown status2
Active, not recruiting1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Peking University First Hospital4
Jinling Hospital, China2
Cancer Foundation, China1
Cancer Institute and Hospital, Chinese Academy of Medical Sciences1
Fuda Cancer Hospital, Guangzhou1
Fudan University1
Peking University Third Hospital1
RenJi Hospital1
Shao Pengfei1
The First Affiliated Hospital of Xiamen University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Kidney Neoplasms18
Carcinoma, Renal Cell12
Carcinoma2
Kidney Diseases2
Neoplasms2
Urogenital Neoplasms2
Birt-Hogg-Dube Syndrome1
Breast Neoplasms1
Disease1
Esophageal Neoplasms1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.